Aethlon Medical, Inc.AEMDNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
+1.9%/yr
vs +14.8%/yr prior
Acceleration
-13.0pp
Decelerating
Percentile
P85
Within normal range
vs 3Y Ago
1.1x
Modest growth
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 34.49% |
| Q3 2025 | 56.00% |
| Q2 2025 | 78.80% |
| Q1 2025 | -366.28% |
| Q4 2024 | 37.68% |
| Q3 2024 | -9.52% |
| Q2 2024 | -36.96% |
| Q1 2024 | 33.33% |
| Q4 2023 | -13.11% |
| Q3 2023 | 12.86% |
| Q2 2023 | -26.13% |
| Q1 2023 | 10.48% |
| Q4 2022 | 32.61% |
| Q3 2022 | 3.16% |
| Q2 2022 | 22.76% |
| Q1 2022 | -50.00% |
| Q4 2021 | -26.15% |
| Q3 2021 | 20.25% |
| Q2 2021 | -5.16% |
| Q1 2021 | 23.27% |
| Q4 2020 | -37.41% |
| Q3 2020 | -0.68% |
| Q2 2020 | 33.03% |
| Q1 2020 | 23.24% |
| Q4 2019 | 78.00% |
| Q3 2019 | 20.80% |
| Q2 2019 | -25.10% |
| Q1 2019 | 22.12% |
| Q4 2018 | -42.38% |
| Q3 2018 | -21.38% |
| Q2 2018 | 19.33% |
| Q1 2018 | 1.56% |
| Q4 2017 | 43.70% |
| Q3 2017 | 30.99% |
| Q2 2017 | 3.83% |
| Q1 2017 | -42.94% |
| Q4 2016 | 47.68% |
| Q3 2016 | -4.13% |
| Q2 2016 | -70.56% |
| Q1 2016 | -2.33% |